Stay updated with breaking news from Robertm Plenge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tufton Capital Management decreased its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 1.8% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 142,854 shares of the biopharmaceutical company’s stock after selling 2,548 shares during the quarter. Bristol-Myers Squibb […]
LMG Wealth Partners LLC increased its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 5.2% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 36,562 shares of the biopharmaceutical company’s stock after purchasing an additional 1,799 shares during the quarter. LMG Wealth […]
Bristol-Myers Squibb (NYSE:BMY – Get Free Report) shares hit a new 52-week low during mid-day trading on Monday . The company traded as low as $55.75 and last traded at $55.75, with a volume of 23794 shares traded. The stock had previously closed at $56.66. Analyst Upgrades and Downgrades A number of brokerages recently issued […]
IFM Investors Pty Ltd lifted its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 3.7% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 435,471 shares of the biopharmaceutical company’s stock after buying an additional 15,445 shares during the quarter. IFM Investors […]
Wright Investors Service Inc. reduced its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 16.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 123,545 shares of the biopharmaceutical company’s stock after selling 24,006 shares during the quarter. Bristol-Myers Squibb accounts for approximately […]